Why NICE Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

Gainers PhenomeX Inc. (NASDAQ: CELL) shares surged 138.3% to $0.9532. Bruker Corporation and PhenomeX reported a $108 million definitive agreement for Bruker to acquire PhenomeX in an all-cash transaction for $1 per share.

Gainers

  • PhenomeX Inc. (NASDAQ:CELL) shares surged 138.3% to $0.9532. Bruker Corporation and PhenomeX reported a $108 million definitive agreement for Bruker to acquire PhenomeX in an all-cash transaction for $1 per share.
  • Tivic Health Systems, Inc. (NASDAQ:TIVC) shares jumped 39.1% to $0.0932. Tivic Health Systems shares jumped 80% on Wednesday after the company announced its funded study started enrollment for its non-invasive bioelectronic device approach to vagus nerve stimulation.
  • Sunlight Financial Holdings Inc. (NYSE:SUNL) climbed 36.9% to $0.2101 after declining 8% on Wednesday.
  • Advanced Health Intelligence Ltd. (NASDAQ:AHI) shares rose 30.2% to $5.00. Advanced Health Intelligence said it obtained overseas R&D reimbursement under Australia’s research and development tax incentive scheme.
  • Troika Media Group, Inc. (NASDAQ:TRKA) climbed 29% to $1.3794.
  • LSI Industries Inc. (NASDAQ:LYTS) gained 21.8% to $15.55 following better-than-expected fourth-quarter results.
  • BioNexus Gene Lab Corp. (NASDAQ:BGLC) surged 22.2% to $0.88.
  • ETAO International Co., Ltd. (NASDAQ:ETAO) rose 21% to $0.5600.
  • Ascent Solar Technologies, Inc. (NASDAQ:ASTI) gained 18.8% to $0.0799.
  • Super Group (SGHC) Limited (NASDAQ:SGHC) jumped 18.7% to $3.4785 following strong quarterly results.
  • Catalyst Biosciences, Inc. (NASDAQ:CBIO) jumped 16.2% to $0.51.
  • Recruiter.com Group, Inc. (NASDAQ:RCRT) gained 15.1% to $0.2139. Job Mobz announced plans to acquire iconic Recruiter.com brand in cash and stock deal.
  • Gambling.com Group Limited (NASDAQ:GAMB) gained 14.3% to $14.51 as the company posted upbeat second-quarter results and raised FY23 guidance.
  • LQR House Inc. (NASDAQ:LQR) surged 13.5% to $1.93.
  • Modular Medical, Inc. (NASDAQ:MODD) shares gained 13.2% to $1.1550 after the company announced a partnership with Phillips-Medisize to expand insulin delivery alternatives.
  • Datasea Inc. (NASDAQ:DTSS) rose 10.3% to $0.59. Datasea announced a $4 million private placement priced at a 125% premium to market at $1.35 per share.
  • The Children’s Place, Inc. (NASDAQ:PLCE) jumped 9.4% to $29.01. Children’s Place reported a second-quarter FY23 sales decline of 9.3% year-on-year to $345.59 million, beating the analyst consensus of $342.64 million.
  • Avnet, Inc. (NYSE:AVT) gained 9.6% to $49.28 following strong quarterly results.
  • Triumph Group, Inc. (NYSE:TGI) rose 8.1% to $9.04.
  • Knightscope, Inc. (NASDAQ:KSCP) gained 6.8% to $1.2694 after falling 10% on Wednesday. The company recently posted upbeat quarterly results.

Losers

  • Creative Realities, Inc. (NASDAQ:CREX) shares fell 35.6% to $1.9050 after the company reported pricing of $6 million public offering of 3 million shares of common stock at $2 per share.
  • EMCORE Corporation (NASDAQ:EMKR) fell 35.6% to $0.4889 after the company reported pricing of $15.8 million public offering.
  • Tremor International Ltd (NASDAQ:TRMR) fell 29.6% to $4.41 after the company reported financial and operating results for the three and six months ended June 30, 2023.
  • China Liberal Education Holdings Limited (NASDAQ:CLEU) fell 22.7% to $0.3363.
  • Amyris, Inc. (NASDAQ:AMRS) fell 21.3% to $0.0630.
  • Natural Alternatives International, Inc. (NASDAQ:NAII) fell 21.3% to $5.49. Natural Alternatives announced temporary closure of its new facility in Carlsbad, California.
  • Check-Cap Ltd. (NASDAQ:CHEK) fell 20.8% to $2.4374. Keystone Dental Holdings and Check-Cap entered into definitive business combination agreement.
  • KULR Technology Group, Inc. (NYSE:KULR) shares tumbled 18.4% to $0.8811 after the company reported second-quarter financial results and announced a proposed public offering of common stock.
  • Wolfspeed, Inc. (NYSE:WOLF) fell 18.4% to $43.40 after the company reported mixed fourth-quarter financial results and issued first-quarter adjusted EPS guidance below estimates.
  • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) fell 18.2% to $0.1551.
  • Hawaiian Electric Industries, Inc. (NYSE:HE) fell 17.7% to $11.70 following a report suggesting the company is facing multiple lawsuits alleging negligence over the Maui fires and is intalks with financial restructuring firms.
  • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) declined 16.3% to $0.1516.
  • Akari Therapeutics, Plc (NASDAQ:AKTX) fell 14.4% to $3.21.
  • Asure Software, Inc. (NASDAQ:ASUR) fell 14.2% to $11.89 after the company reported pricing of public offering of common stock.
  • AdaptHealth Corp. (NASDAQ:AHCO) fell 13.8% to $11.61.
  • UroGen Pharma Ltd. (NASDAQ:URGN) fell 12.9% to $18.70.
  • Calliditas Therapeutics AB (NASDAQ:CALT) declined 11.5% to $16.36 following second-quarter results..
  • Gold Fields Limited (NYSE:GFI) fell 11.4% to $11.27 as the company reported a decline in EPS for the half year.
  • CVS Health Corporation (NYSE:CVS) declined 10.6% to $64.98 following reports that Blue Shield of California plans to drop CVS’s Caremark as its pharmacy benefit manager.
  • Digital Brands Group, Inc. (NASDAQ:DBGI) fell 10.3% to $0.70 after jumping 91% on Wednesday.
  • NICE Ltd. (NASDAQ:NICE) fell 9.7% to $190.96 after the company reported second-quarter financial results and issued guidance.
  • Akumin Inc. (NASDAQ:AKU) shares fell 9.5% to $0.1511 after jumping 22% on Wednesday.
  • Madison Square Garden Sports Corp. (NYSE:MSGS) fell 7.1% to $190.99 following mixed fourth-quarter results and a decline in revenues.

Now Read This: Ethereum Tumbles Below $1,800 Following Jobless Claims Data; Sei Becomes Top Loser

Total
0
Shares
Related Posts
Read More

Ford Rides On The Strength Of Pro, Says Analyst

Analyst John Murphy of BofA Securities reiterates Buy rating for Ford, citing strong operational performance driven by Pro volume growth and improved Model e losses. Despite tax challenges, Ford's 2024 outlook remains steady with slight adjustments in FCF and Capex. Murphy believes Ford's resilience amid pricing pressure and high demand for Pro bode well for future growth prospects.

F